Literature DB >> 24559489

Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome.

C Roubaud Baudron1, X Panhard2, O Clermont2, F Mentré2, B Fantin2, E Denamur2, A Lefort2.   

Abstract

To explore the specificities of Escherichia coli bacteraemia in the elderly, the demographic, clinical and bacteriological characteristics and in-hospital mortality rate of 'young' (18-64 years, n = 395), 'old' (65-79 years, n = 372) and 'very old' (⩾80 years, n = 284) adult patients of the multicentre COLIBAFI cohort study were compared. Clinical and bacteriological risk factors for death were jointly identified by logistic regression and multivariate analysis within each group. 'Young' and 'old' patients had more comorbidities than 'very old' patients (comorbidity score: 1·5 ± 1·3 and 1·6 ± 1·2 vs. 1·2 ± 1·2, respectively; P < 0·001), and were more frequently nosocomially infected (22·3% and 23·8% vs. 8·8%, respectively; P < 0·001). 'Old' patients had the poorest prognosis (death rate: 16·4% vs.10·4% for 'young' and 12·0% for 'very old' patients, respectively; P = 0·039). Risk factors for death were age group-specific, suggesting a host-pathogen relationship evolving with age.

Entities:  

Mesh:

Year:  2014        PMID: 24559489      PMCID: PMC9151316          DOI: 10.1017/S0950268814000211

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  48 in total

1.  Characterization of a putative virulence island in the chromosome of uropathogenic Escherichia coli possessing a gene encoding a uropathogenic-specific protein.

Authors:  H Kurazono; S Yamamoto; M Nakano; G B Nair; A Terai; W Chaicumpa; H Hayashi
Journal:  Microb Pathog       Date:  2000-03       Impact factor: 3.738

2.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

Review 3.  Urinary tract infections in long-term-care facilities.

Authors:  L E Nicolle
Journal:  Infect Control Hosp Epidemiol       Date:  2001-03       Impact factor: 3.254

4.  Adjusted mortality after hip fracture: From the cardiovascular health study.

Authors:  John A Robbins; Mary L Biggs; Jane Cauley
Journal:  J Am Geriatr Soc       Date:  2006-12       Impact factor: 5.562

5.  A novel genetic island of meningitic Escherichia coli K1 containing the ibeA invasion gene (GimA): functional annotation and carbon-source-regulated invasion of human brain microvascular endothelial cells.

Authors:  S H Huang; Y H Chen; G Kong; S H Chen; J Besemer; M Borodovsky; A Jong
Journal:  Funct Integr Genomics       Date:  2001-09       Impact factor: 3.410

6.  Bacteraemia in the elderly: predictors of outcome in an urban teaching hospital.

Authors:  Benjamin M Greenberg; Robert L Atmar; Charles E Stager; Stephen B Greenberg
Journal:  J Infect       Date:  2005-05       Impact factor: 6.072

7.  Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia.

Authors:  Jose A Martínez; Sara Soto; Anna Fabrega; Manel Almela; Josep Mensa; Alex Soriano; Francesc Marco; María T Jimenez de Anta; Jordi Vila
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

8.  Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group.

Authors:  C Brun-Buisson; F Doyon; J Carlet
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

9.  Is presentation of bacteremia in the elderly the same as in younger patients?

Authors:  P Chassagne; M B Perol; J Doucet; C Trivalle; J F Ménard; N D Manchon; Y Moynot; G Humbert; J Bourreille; E Bercoff
Journal:  Am J Med       Date:  1996-01       Impact factor: 4.965

10.  Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.

Authors:  Olivier Clermont; Hiran Dhanji; Mathew Upton; Tarek Gibreel; Andrew Fox; David Boyd; Michael R Mulvey; Patrice Nordmann; Etienne Ruppé; Jean Louis Sarthou; Thierry Frank; Sophie Vimont; Guillaume Arlet; Catherine Branger; Neil Woodford; Erick Denamur
Journal:  J Antimicrob Chemother       Date:  2009-05-27       Impact factor: 5.790

View more
  5 in total

1.  Comparative Pathogenomics of Escherichia coli: Polyvalent Vaccine Target Identification through Virulome Analysis.

Authors:  J R Clark; A M Maresso
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

Review 2.  Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field.

Authors:  Jan T Poolman; Michael Wacker
Journal:  J Infect Dis       Date:  2015-09-02       Impact factor: 5.226

3.  Genetic analysis of invasive Escherichia coli in Scotland reveals determinants of healthcare-associated versus community-acquired infections.

Authors:  Cosmika Goswami; Stephen Fox; Matthew Holden; Martin Connor; Alistair Leanord; Thomas J Evans
Journal:  Microb Genom       Date:  2018-06-22

4.  Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants.

Authors:  Megumi Inoue; Tetsuro Ogawa; Hiroshi Tamura; Yosuke Hagiwara; Yuki Saito; Darren Abbanat; Germie van den Dobbelsteen; Peter Hermans; Stefan Thoelen; Jan Poolman; Patricia Ibarra de Palacios
Journal:  Hum Vaccin Immunother       Date:  2018-06-28       Impact factor: 3.452

5.  Major role of iron uptake systems in the intrinsic extra-intestinal virulence of the genus Escherichia revealed by a genome-wide association study.

Authors:  Marco Galardini; Olivier Clermont; Alexandra Baron; Bede Busby; Sara Dion; Sören Schubert; Pedro Beltrao; Erick Denamur
Journal:  PLoS Genet       Date:  2020-10-28       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.